KATIE BROUILLARD O'BRIEN NP
Prescription History 1801048921
Dermatology in Worcester, MA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for KATIE BROUILLARD O'BRIEN NP, an active Dermatology specialist practicing in Worcester, MA. Our medical registry currently tracks 10 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 356 documented patient claims. Among these therapy options, the most frequently utilized medication is Ketoconazole, which accounts for 98 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other MA PrescribersVs. MA Avg |
|---|---|---|---|
| Ketoconazole | 98 | $19.29 | ▲ More than typical |
About Ketoconazole: Ketoconazole is used to treat skin infections such as athlete's foot, jock itch, ringworm, and certain kinds of dandruff. Show more ▾ This medication is also used to treat a skin condition known as pityriasis (tinea versicolor), a fungal infection that causes a lightening or darkening of the skin of the neck, chest, arms, or legs. Ketoconazole is an azole antifungal that works by preventing the growth of fungus. Broad spectrum antifungal agent used for long periods at high doses, especially in immunosuppressed patients. In 2024, this provider wrote 98 Medicare prescriptions for Ketoconazole, about 2.2 times the volume of the typical Massachusetts prescriber of this medication (45.1). Medicare paid an average of $19.29 per fill, versus $19.09 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 104 30-Day Fills standardized to 30-day supplies 2,847 Days of Medication total across all patients in 2024 | |||
| Clobetasol Propionate | 58 | $40.80▼ below MA avg | ▲ More than typical |
About Clobetasol Propionate: This medication is used to treat a variety of skin conditions (such as eczema, psoriasis, dermatitis, allergies, rash). Show more ▾ Clobetasol reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a very strong (super-high-potency) corticosteroid. A derivative of PREDNISOLONE with high glucocorticoid activity and low mineralocorticoid activity. Absorbed through the skin faster than FLUOCINONIDE, it is used topically in treatment of PSORIASIS but may cause marked adrenocortical suppression. In 2024, this provider wrote 58 Medicare prescriptions for Clobetasol Propionate, about 1.7 times the volume of the typical Massachusetts prescriber of this medication (35). Medicare paid an average of $40.80 per fill, versus $68.05 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 64 30-Day Fills standardized to 30-day supplies 1,829 Days of Medication total across all patients in 2024 | |||
| Metronidazole | 49 | $48.71 | ▲ More than typical |
About Metronidazole: Metronidazole is an antibiotic that is used to treat a wide variety of infections. Show more ▾ It works by stopping the growth of certain bacteria and parasites. This antibiotic treats only certain bacterial and parasitic infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Metronidazole may also be used with other medications to treat certain stomach/intestinal ulcers caused by a bacteria (H. pylori). A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS. In 2024, this provider wrote 49 Medicare prescriptions for Metronidazole, about 1.8 times the volume of the typical Massachusetts prescriber of this medication (27.7). Medicare paid an average of $48.71 per fill, versus $36.70 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 53 30-Day Fills standardized to 30-day supplies 1,570 Days of Medication total across all patients in 2024 | |||
| Triamcinolone Acetonide | 46 | $11.20 | ▲ More than typical |
About Triamcinolone Acetonide: This medication is used to treat a variety of skin conditions (such as eczema, dermatitis, allergies, rash). Show more ▾ Triamcinolone reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a medium- to strong-potency corticosteroid. The potency depends on the strength and the form that you use. For details on the potency of your product, ask your pharmacist. An esterified form of TRIAMCINOLONE. It is an anti-inflammatory glucocorticoid used topically in the treatment of various skin disorders. Intralesional, intramuscular, and intra-articular injections are also administered under certain conditions. In 2024, this provider wrote 46 Medicare prescriptions for Triamcinolone Acetonide, about 1.3 times the volume of the typical Massachusetts prescriber of this medication (34.8). Medicare paid an average of $11.20 per fill, versus $10.62 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 47 30-Day Fills standardized to 30-day supplies 1,351 Days of Medication total across all patients in 2024 | |||
| OtezlaApremilast | 25 | $4,675.53▼ below MA avg | ≈ Typical |
About Otezla: This medication is used to treat a certain type of arthritis (psoriatic arthritis). Show more ▾ Apremilast is also used to treat a certain type of skin condition (moderate to severe plaque psoriasis). Apremilast belongs to a class of drugs known as phosphodiesterase 4 (PDE4) inhibitors. For the treatment of psoriatic arthritis, it decreases pain and swelling, and may help improve flexibility in the affected joints. For the treatment of plaque psoriasis, it may help to reduce the redness, thickening, and scaling of the skin that occurs with this condition. Apremilast is also used to treat mouth sores in people who have Behcet's disease. It helps to reduce the pain and improve the healing of these mouth sores. A PDE4 inhibitor with anti-ulcer activity. In 2024, this provider wrote 25 Medicare prescriptions for Otezla, about the same volume as the typical Massachusetts prescriber of this medication (24.9). Medicare paid an average of $4,675.53 per fill, versus $4,681.43 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 25 30-Day Fills standardized to 30-day supplies 750 Days of Medication total across all patients in 2024 | |||
| Fluorouracil | 18 | $35.67▼ below MA avg | ▼ Less than typical |
About Fluorouracil: This medication is used on the skin to treat pre-cancerous and cancerous skin growths. Show more ▾ Fluorouracil belongs to a class of medications known as anti-metabolites. It works by blocking the growth of abnormal cells that cause the skin condition. A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. In 2024, this provider wrote 18 Medicare prescriptions for Fluorouracil, about a third of the volume of the typical Massachusetts prescriber of this medication (46.5). Medicare paid an average of $35.67 per fill, versus $55.91 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 18 30-Day Fills standardized to 30-day supplies 540 Days of Medication total across all patients in 2024 | |||
| Nystatin | 18 | $15.78▼ below MA avg | ≈ Typical |
About Nystatin: Nystatin is used to treat fungal skin infections. Show more ▾ Nystatin is an antifungal that works by stopping the growth of fungus. Macrolide antifungal antibiotic complex produced by Streptomyces noursei, S. aureus, and other Streptomyces species. The biologically active components of the complex are nystatin A1, A2, and A3. In 2024, this provider wrote 18 Medicare prescriptions for Nystatin, about 76% of the volume of the typical Massachusetts prescriber of this medication (23.7). Medicare paid an average of $15.78 per fill, versus $18.05 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 18 30-Day Fills standardized to 30-day supplies 540 Days of Medication total across all patients in 2024 | |||
| Betamethasone Dipropionate | 16 | $34.14▼ below MA avg | ▼ Less than typical |
About Betamethasone Dipropionate: This medication is used to treat a variety of skin conditions (such as eczema, dermatitis, allergies, rash). Show more ▾ Betamethasone reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a strong corticosteroid. A glucocorticoid given orally, parenterally, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. Its lack of mineralocorticoid properties makes betamethasone particularly suitable for treating cerebral edema and congenital adrenal hyperplasia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p724) In 2024, this provider wrote 16 Medicare prescriptions for Betamethasone Dipropionate, about half the volume of the typical Massachusetts prescriber of this medication (33.3). Medicare paid an average of $34.14 per fill, versus $41.75 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 16 30-Day Fills standardized to 30-day supplies 322 Days of Medication total across all patients in 2024 | |||
| Hydrocortisone | 15 | $8.49▼ below MA avg | ▼ Less than typical |
About Hydrocortisone: This medication is used to treat a variety of skin conditions (such as insect bites, poison oak/ivy, eczema, dermatitis, allergies, rash, itching of the outer female genitals, anal itching). Show more ▾ Hydrocortisone reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a mild corticosteroid. The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. In 2024, this provider wrote 15 Medicare prescriptions for Hydrocortisone, about half the volume of the typical Massachusetts prescriber of this medication (27). Medicare paid an average of $8.49 per fill, versus $15.44 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 15 30-Day Fills standardized to 30-day supplies 342 Days of Medication total across all patients in 2024 | |||
| Skyrizi PenRisankizumab-Rzaa | 13 | $19,861.65▼ below MA avg | ▼ Less than typical |
About Skyrizi Pen: This medication is used to treat plaque psoriasis and psoriatic arthritis. Show more ▾ It is also used to treat certain bowel diseases (Crohn's disease, ulcerative colitis). Risankizumab belongs to a class of drugs known as monoclonal antibodies. It works by blocking a certain natural protein in your body (interleukin-23) that may cause inflammation and swelling. A fully human IgG1 mAb selective for IL-23A; for treatment of moderate-to-severe psoriasis. In 2024, this provider wrote 13 Medicare prescriptions for Skyrizi Pen, about 74% of the volume of the typical Massachusetts prescriber of this medication (17.5). Medicare paid an average of $19,861.65 per fill, versus $20,448.04 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 34.6 30-Day Fills standardized to 30-day supplies 1,036 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for KATIE BROUILLARD O'BRIEN NP is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Dermatology prescribing approach at this Worcester, MA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among MA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
